Unexplainable Ecstasy therapy
9 snips
Aug 7, 2024 Explore the shift of MDMA from a party drug to a potential PTSD treatment as the FDA gears up for a landmark decision. Hear moving personal stories from veterans grappling with trauma and their journey through MDMA-assisted therapy. Discover the passionate advocacy efforts driving change amid political hurdles. The evolving views on psychedelics reveal the complexities of mental health and drug policies, shedding light on a powerful new path to healing.
AI Snips
Chapters
Transcript
Episode notes
Veteran's PTSD Journey
- Jonathan Lubecchi, an Army sergeant, experienced PTSD after serving in Iraq.
- He tried various treatments through the VA, but none fully alleviated his symptoms.
Discovering MDMA Therapy
- After a suicide attempt, Jonathan learned about MDMA-assisted therapy for PTSD.
- He enrolled in a clinical trial organized by MAPS, a group advocating for psychedelic therapy.
MAPS' Strategy
- MAPS founder Rick Doblin aims to gain FDA approval for MDMA as medicine.
- He strategically focuses on veterans with PTSD due to public sympathy and lack of effective treatments.